PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thermo Fisher Scientific Extends Linear Ion Trap and Triple Stage Quadrupole Mass Spectrometer Trade-in Program - Thermo Fisher Scientific Inc., the world leader in serving science, announces the extension of its LC-MS ion trap and triple stage quadrupole trade-in programs to include the trade-in of instruments from any vendor (NYSE: TMO)
Thermo Fisher Scientific Extends Linear Ion Trap and Triple Stage Quadrupole Mass Spectrometer Trade-in Program

 

NewswireToday - /newswire/ - San Jose, CA, United States, 2010/06/14 - Thermo Fisher Scientific Inc., the world leader in serving science, announces the extension of its LC-MS ion trap and triple stage quadrupole trade-in programs to include the trade-in of instruments from any vendor (NYSE: TMO).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Scientists are invited to participate in the Traps and Triples Trade-In Program by trading in ion trap or triple stage quadrupole mass spectrometers - from any vendor - and upgrading to Thermo Scientific linear ion trap or triple stage quadrupole technology.

Available through September 2010, new and existing customers are eligible to trade in any model of ion trap or triple stage quadrupole mass spectrometer for a discounted price on a new Thermo Scientific linear ion trap or triple stage quadrupole mass spectrometer. Thermo Fisher is offering its complete line of ion trap and triple stage quadrupole mass spectrometers through the promotional period. Both product lines offer models suitable for a range of uses, from routine analyses to research applications.

Building on a strong tradition of innovation, the Thermo Scientific LTQ Series mass spectrometers provide enhanced performance for complex sample analyses. The Thermo Scientific LTQ XL is equipped with powerful tools to generate extensive structural information while providing exceptional sensitivity and flexibility. The Thermo Scientific LCQ Fleet provides rich information for routine analysis of complex samples with high throughput and provides excellent full-scan sensitivity, ruggedness and reliability.

Thermo Scientific TSQ Series mass spectrometers are among the most advanced and powerful triple stage quadrupole mass spectrometers available. The Thermo Scientific TSQ Quantum Ultra is ideal for quantitative applications and provides ultimate productivity and faster method development at high specificity. The Thermo Scientific TSQ Quantum Access MAX is suitable for a variety of applications and provides remarkable specificity at an affordable price for exceptional price to performance.

Scientists interested in obtaining the latest breakthrough technology in mass spectrometry can trade in their old ion trap or triple stage quadrupole mass spectrometers for a new Thermo Scientific LTQ Velos or Thermo Scientific TSQ Vantage. Scientists can upgrade the analytical power of their laboratory with the world's fastest and most sensitive LC-MS ion trap, the LTQ Velos, or the advanced triple stage quadrupole TSQ Vantage. Both of these instruments utilize advanced S-Lens ion optics, which improve instrument sensitivity and data acquisition rates by collecting and focusing more of the ions as they travel from the ion source to the mass analyzer.

The extension of the trade-in program provides new and existing customers with access to the latest technological advancements in mass spectrometry, including greater sensitivity and enhanced robustness that lead to improved results and increased productivity. Long-term success is ensured with continued instrument support throughout the life of the instrument.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (thermo.com) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thermo Fisher Scientific Extends Linear Ion Trap and Triple Stage Quadrupole Mass Spectrometer Trade-in Program

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Eleanor Thouret - Scottpr.com 
+44 1477 539539 thermo[.]scottpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)